Abstract
Metastatic brain tumors are the most common intracranial tumors in adults and the most common cause of neurologic morbidity and mortality in these patients. Recent advances in the management of the primary cancer have resulted in improved prognosis, longer survival, and thus, increased identification of the presence of brain metastases. Data suggest that aggressive treatment of the metastatic brain tumor with surgical resection increases the length of survival in these patients. New techniques, including preoperative functional imaging, stereotactic surgical resection, image-guided neurosurgery, intraoperative ultrasound, and cortical mapping, have aided neurosurgeons in surgical resection and have helped to lower the associated surgical morbidity and mortality. The respective roles of surgery, patient selection, prognostic factors, and radiotherapy are addressed in this review.
Similar content being viewed by others
References and Recommended Reading
Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6–29.
Sawaya R, Bindal RK, Lang FF, et al.: Metastatic brain tumors. In Brain Tumors: An Encyclopedic Approach. Edited by Kaye AH and Laws ER. Edinburgh: Churchill Livingstone; 2001:999–1026. This is the most comprehensive contemporary reference on metastatic brain tumors. It details the epidemiology, pathology, biology, management and clinical decision making, and therapeutic alternatives for patients with metastatic brain tumors.
Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579–592.
Sundaresan N, Galicich JH: Surgical treatment of brain metastases: clinical and computerized tomography evaluation of the results of treatment. Cancer 1985, 55:1382–1388.
Kelly PJ, Kall BA, Goerss SJ: Results of computed tomography-based computer-assisted stereotactic resection of metastatic intracranial tumors. Neurosurgery 1988, 22:7–17.
Bindal RK, Sawaya R, Leavens ME, et al.: Surgical treatment of multiple brain metastases. J Neurosurg 1993, 79:210–216.
Bindal RK, Sawaya R, Leavens ME, et al.: Reoperation for recurrent metastatic brain tumors. J Neurosurg 1995, 83:600–604.
Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.
Bucholz A: Kasuistischer Beitrag zur Kenntis der Karzinome des Zentralnervensystems [German]. Monatsschr Psychiatr Neurol 1898, 4:183–210.
Grant FC: Concerning intracranial malignant metastases: their frequency and the value of surgery in their treatment. Ann Surg 1926, 84:635–646.
Oldberg E: Surgical considerations of carcinomatous metastases to the brain. JAMA 1933, 101:1458–1461.
Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583–590.
Galicich JH, Sundaresan N, Arbit E, et al.: Surgical treatment of single brain metastasis: factors associated with survival. Cancer 1980, 45:381–386.
Sampson JH, Carter JH Jr, Friedman AH, et al.: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11–20.
York JE, Stringer J, Ajani JA, et al.: Gastric cancer and metastasis to the brain. Ann Surg Oncol 1999, 6:771–776.
Farnell GF, Buckner JC, Cascino TL, et al.: Brain metastases from colorectal carcinoma: the long term survivors. Cancer 1996, 78:711–716.
Lagerwaard FJ, Levendag PC, Nowak PJ, et al.: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795–803. This is a report from a retrospective study in a single institution of 1292 patients with metastatic brain tumors in which improved survival by surgical resection is supported. This paper also lists prognostic factors (performance status, response to steroid treatment, systemic tumor activity, serum lactate dehydrogenase, site of primary tumor, age, and number of brain metastases) that can be used to construct favorable and unfavorable subgroups of patients with brain metastases.
Nussbaum ES, Djalilian HR, Cho KH, et al.: Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781–1788.
Pieper DR, Hess KR, Sawaya RE: Role of surgery in the treatment of brain metastases in patients with breast cancer. Ann Surg Oncol 1997, 4:481–490.
Lang FF, Sawaya R: Surgical management of cerebral metastases. Neurosurg Clin N Am 1996, 7:459–484.
Lang FF, Sawaya R: Surgical treatment of metastatic brain tumors. Semin Surg Oncol 1998, 14:53–63.
Hsiung CY, Leung SW, Wang CJ, et al.: The prognostic factors of lung cancer patients with brain metastases treated with radiotherapy. J Neurooncol 1998, 36:71–77.
Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000, 93:9–18. In this reported study, 91 patients with metastatic melanoma were treated with surgical excision. The results are important because they document the negative impact on outcome of subtotally resected lesions, presence of systemic metastases, and infratentorially located lesions. The data also raise a question about the usefulness of WBRT following resection.
Wronski M, Arbit E, McCormick B, et al.: Surgical treatment of 70 patients with brain metastases from breast carcinoma. Cancer 1997, 80:1746–1754.
Wronski M, Arbit E: Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 1999, 85:1677–1685. This paper documents the improved outcome of patients with metastatic colon carcinoma to the brain who are treated with resection of the metastatic lesion. Whereas posterior fossa lesions were noted to be a negative prognostic factor, gender, presence of multiple metastases, presence of lung lesions, and adjuvant brain radiotherapy after craniotomy appeared to have no impact on survival. Resection of recurrent metastases was noted to improve survival as well.
Bokemeyer C, Nowak P, Haupt A, et al.: Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 1997, 15:1449–1454.
Saitoh Y, Fujisawa T, Shiba M, et al.: Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999, 24:99–106.
Wood CC, Spencer DD, Allison T, et al.: Localization of human sensorimotor cortex during surgery by cortical surface recording of somatosensory evoked potentials. J Neurosurg 1988, 68:99–111.
Roberts DW, Strohbehn JW, Hatch JF: A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope. J Neurosurg 1986, 65:545–549.
Hammoud MA, Ligon BL, elSouki R, et al.: Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996, 84:737–741.
Boogerd W, Hart AA, Tjahja IS: Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer. J Neurooncol 1997, 35:161–167.
Elvidge AR, Baldwin M: Clinical analysis of eighty-eight cases of metastatic carcinoma involving the central nervous system with an outline of therapeutic principles. J Neurosurg 1949, 6:495–502.
Haar F, Patterson RHJ: Surgery for metastatic intracranial neoplasm. Cancer 1972, 30:1241–1245.
Sundaresan N, Sachdev VP, DiGiacinto GV, et al.: Reoperation for brain metastases. J Clin Oncol 1988, 6:1625–1629.
Skibber JM, Soong SJ, Austin L, et al.: Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996, 3:118–123.
Stuschke M, Eberhardt W, Pottgen C, et al.: Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol 1999, 17:2700–2709. Low-dose prophylactic cranial irradiation for patients with non-smallcell lung cancer is demonstrated to decrease the rate of brain metastases as the first site of relapse. The long-term neuropsychological side effects are minimal, and there were minimal MRI indications of radiationinduced injury.
Sundaresan N, Galicich JH, Deck MD, et al.: Radiation necrosis after treatment of solitary intracranial metastases. Neurosurgery 1981, 8:329–333.
Alexander E III, Loeffler JS: Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am 1992, 3:167–190.
Mehta M, Noyes W, Craig B, et al.: A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys 1997, 39:445–454.
Rutigliano MJ, Lunsford LD, Kondziolka D, et al.: The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery 1995, 37:445–453.
Auchter RM, Lamond JP, Alexander E, et al.: A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996, 35:27–35.
Bindal AK, Bindal RK, Hess KR, et al.: Surgery versus radiosurgery in the treatment of brain metastasis. J Neurosurg 1996, 84:748–754.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weinberg, J.S., Lang, F.F. & Sawaya, R. Surgical management of brain metastases. Curr Oncol Rep 3, 476–483 (2001). https://doi.org/10.1007/s11912-001-0068-6
Issue Date:
DOI: https://doi.org/10.1007/s11912-001-0068-6